Related Experiment Video
Updated: Oct 2, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments
Osnat C Melamed1, Wayne K deRuiter2, Leslie Buckley3
1Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada; Department of Family and Community Medicine, University of Toronto, 500 University Avenue, Toronto, Ontario M5G1V7, Canada.
Abstract:
Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from in-person to remote care delivery. This review discusses the following evidence regarding changes prompted by the COVID pandemic to the clinical care of individuals with SUDs: (1) reduction in availability of care, (2) increase in demand for care, (3) transition to telemedicine use, (4) telemedicine for treatment of opioid use disorders, and (5) considerations for use of telemedicine in treating SUDs.
More Related Videos
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

